Cellebrite's stock fell 6.29% in pre-market trading on Wednesday, following the release of its fourth-quarter 2025 financial results.

The digital investigative solutions company reported quarterly net income of $21.261 million, which fell short of the analyst consensus estimate of $34 million. This miss on a key profitability metric appears to have driven the negative investor reaction.

Other aspects of the earnings report were more positive, including revenue of $128.821 million that beat estimates and adjusted earnings per share of $0.14 that met expectations. The company also provided full-year 2026 revenue guidance of $565 million to $571 million.